Quest outlines 2026 revenue $11.78B-$11.9B and adjusted EPS $10.63-$10.83 as it raises guidance (NYSE:DGX)
Summary
Quest Diagnostics (DGX) Q1 2026 earnings call recap: 9% organic growth, raised revenue/EPS guidance, Corewell/Fresenius mix, AI traction & PAMA risks—read...
Description
Quest Diagnostics (DGX) Q1 2026 earnings call recap: 9% organic growth, raised revenue/EPS guidance, Corewell/Fresenius mix, AI traction & PAMA risks—read...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source